Cobicistat, sold under the brand name Tybost, is a medication for use in the treatment of human immunodeficiency virus infection . Its major mechanism of action is through the inhibition of human CYP3A proteins.

2024年9月11日 · Cobicistat is given together with atazanavir (Reyataz) or darunavir (Prezista) to treat human immunodeficiency virus (HIV), the virus that can cause acquired immunodeficiency syndrome (AIDS). Cobicistat is used to increase your blood levels of these medicines, helping to make them safer and more effective at lower doses.

Cobicistat is used to increase the effects of atazanavir or darunavir for the treatment of human immunodeficiency virus (HIV) infection. HIV is the virus that causes acquired immune deficiency syndrome (AIDS).

Find patient medical information for cobicistat oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Cobicistat is in a class of medications called pharmacokinetic boosters. It works by increasing the amount of atazanavir or darunavir in the body so that they can have a greater effect. How should this medicine be used?

COBICISTAT (koe BIS i stat) is a medication booster. It is used with other medications to treat HIV. This medicine is not a cure for HIV. This medicine can help lower, but not fully prevent, the risk of spreading HIV to others.

2024年5月21日 · Cobicistat (brand name: Tybost) is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for use in adults and children along with the HIV medicines atazanavir (brand name Reyataz) or darunavir (brand name Prezista).

Cobicistat is a CYP3A inhibitor indicated to increase systemic exposure of atazanavir or darunavir (once daily dosing regimen) in combination with other antiretroviral agents in the treatment of HIV-1 infection.